How many insider trades does FilingIQ track for TNGX?

FilingIQ tracks 140 Form 4 insider transactions for TNGX (Tango Therapeutics, Inc.), covering filings from Oct 4, 2022 onwards. 19 of those were filed in the last 90 days.

Are TNGX insiders net buyers or net sellers?

Across the full Form 4 history for TNGX, 14 transactions (10%) were open-market purchases and 72 (51%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TNGX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TNGX in?

Tango Therapeutics, Inc. (TNGX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.72B.

TNGX insider trading

Healthcare

Tango Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

140

Last 90 days

Buys / sells

10% / 51%

Market cap

$1.72B

About Tango Therapeutics, Inc.

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

Company website: www.tangotx.com

TNGX insider activity at a glance

FilingIQ has scored 140 insider transactions for TNGX since Oct 4, 2022. The most recent filing in our index is dated May 1, 2026.

Across the full history, 14 open-market purchases and 72 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TNGX insider trades is 57.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TNGX trades on FilingIQ Raw filings on SEC EDGAR

Latest TNGX Form 4 filings

Boxer Capital Management, LLC

S Nov 6, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading TNGX

Peters Malte

4 trades · score 78.0

13F funds holding TNGX

Artal Group S.A.

$17.43M · 0.4% of AUM

Casdin Capital, LLC

$10.20M · 0.8% of AUM

Samsara BioCapital, LLC

$2.49M · 0.5% of AUM

Frequently asked

How many insider trades does FilingIQ track for TNGX?: FilingIQ tracks 140 Form 4 insider transactions for TNGX (Tango Therapeutics, Inc.), covering filings from Oct 4, 2022 onwards. 19 of those were filed in the last 90 days.
Are TNGX insiders net buyers or net sellers?: Across the full Form 4 history for TNGX, 14 transactions (10%) were open-market purchases and 72 (51%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TNGX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TNGX in?: Tango Therapeutics, Inc. (TNGX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.72B.

Methodology & sources

Every TNGX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.